Literature DB >> 15163738

MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.

Karin E Peterson1, John S Errett, Tao Wei, Derek E Dimcheff, Richard Ransohoff, William A Kuziel, Leonard Evans, Bruce Chesebro.   

Abstract

Virus infection of the central nervous system (CNS) often results in chemokine upregulation. Although often associated with lymphocyte recruitment, increased chemokine expression is also associated with non-lymphocyte-mediated CNS disease. In these instances, the effect of chemokine upregulation on neurological disease is unclear. In vitro, several chemokines including monocyte chemotactic protein 1 (MCP-1) protect neurons from apoptosis. Therefore, in vivo, chemokine upregulation may be a protective host response to CNS damage. Alternatively, chemokines may contribute to pathogenesis by stimulating intrinsic brain cells or recruiting macrophages to the brain. To investigate these possibilities, we studied a neurovirulent retrovirus, Fr98, that induces severe non-lymphocyte-mediated neurological disease and causes the upregulation of several chemokines that bind to chemokine receptors CCR2 and CCR5. Knockout mice deficient in CCR2 had reduced susceptibility to Fr98 pathogenesis, with significantly fewer mice developing clinical disease than did wild-type controls. In contrast, no reduction in Fr98-induced disease was observed in CCR5 knockout mice. Thus, signaling through CCR2, but not CCR5, plays an important role in Fr98-mediated pathogenesis. Three ligands for CCR2 (MCP-1, MCP-3, and MCP-5) were upregulated during Fr98 infection of the brain. Antibody-blocking experiments demonstrated that MCP-1 was important for retrovirus-induced neurological disease. In situ hybridization analysis revealed that MCP-1 was expressed by glial fibrillary acidic protein-positive astrocytes. Thus, astrocytes, previously not thought to play an effector role in the disease process were found to contribute to pathogenesis through the production of MCP-1. This study also demonstrates that chemokines can mediate pathogenesis in the CNS in the absence of lymphocytic infiltrate and gives credence to the hypothesis that chemokine upregulation is a mechanism by which retroviruses such as human immunodeficiency virus induce neurological damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163738      PMCID: PMC416512          DOI: 10.1128/JVI.78.12.6449-6458.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Immunologic tolerance.

Authors:  M Sarzotti
Journal:  Curr Opin Hematol       Date:  1997-01       Impact factor: 3.284

2.  Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells.

Authors:  S J Robertson; K J Hasenkrug; B Chesebro; J L Portis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia.

Authors:  J He; Y Chen; M Farzan; H Choe; A Ohagen; S Gartner; J Busciglio; X Yang; W Hofmann; W Newman; C R Mackay; J Sodroski; D Gabuzda
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

4.  Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain.

Authors:  A R Glabinski; V Balasingam; M Tani; S L Kunkel; R M Strieter; V W Yong; R M Ransohoff
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

5.  Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.

Authors:  X Gong; W Gong; D B Kuhns; A Ben-Baruch; O M Howard; J M Wang
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

6.  Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3.

Authors:  A Ben-Baruch; L Xu; P R Young; K Bengali; J J Oppenheim; J M Wang
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

7.  Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.

Authors:  S L Wesselingh; C Power; J D Glass; W R Tyor; J C McArthur; J M Farber; J W Griffin; D E Griffin
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

8.  Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

Authors:  H Schmidtmayerova; H S Nottet; G Nuovo; T Raabe; C R Flanagan; L Dubrovsky; H E Gendelman; A Cerami; M Bukrinsky; B Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

9.  Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1.

Authors:  M E Fuentes; S K Durham; M R Swerdel; A C Lewin; D S Barton; J R Megill; R Bravo; S A Lira
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

10.  Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1.

Authors:  M N Sarafi; E A Garcia-Zepeda; J A MacLean; I F Charo; A D Luster
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

View more
  27 in total

1.  Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis.

Authors:  Ching G Ng; Diane E Griffin
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses.

Authors:  Amanda C Clase; Derek E Dimcheff; Cynthia Favara; David Dorward; Frank J McAtee; Lindsay E Parrie; David Ron; John L Portis
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.

Authors:  Niranjan B Butchi; Min Du; Karin E Peterson
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

4.  Neuropeptide Y Negatively Influences Monocyte Recruitment to the Central Nervous System during Retrovirus Infection.

Authors:  Tyson A Woods; Min Du; Aaron Carmody; Karin E Peterson
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 5.  Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Authors:  Irena Slavuljica; Daria Kveštak; Peter Csaba Huszthy; Kate Kosmac; William J Britt; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

6.  Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.

Authors:  X Pei; X Fan; H Zhang; H Duan; C Xu; B Xie; L Wang; X Li; Y Peng; T Shen
Journal:  Clin Exp Immunol       Date:  2019-02-17       Impact factor: 4.330

7.  Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.

Authors:  Lisa Kercher; Cynthia Favara; Chi-Chao Chan; Richard Race; Bruce Chesebro
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.

Authors:  Oliver Frank; Michelle Giehl; Chun Zheng; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 9.  Innate immunity in the pathogenesis of polytropic retrovirus infection in the central nervous system.

Authors:  Karin E Peterson; Min Du
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus.

Authors:  Mohammed Khaleduzzaman; Joseph Francis; Meryll E Corbin; Elizabeth McIlwain; Marc Boudreaux; Min Du; Tim W Morgan; Karin E Peterson
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.